Glund, S., & Kreuzer, J. (2017). Effect of age and renal function on idarucizumab pharmacokinetics and idarucizumab-mediated reversal of dabigatran anticoagulant activity in a randomized, double-blind, crossover phase Ib study. Clinical pharmacokinetics, 56(1), . https://doi.org/10.1007/s40262-016-0417-0
Chicago Style (17th ed.) CitationGlund, Stephan, and Jörg Kreuzer. "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-blind, Crossover Phase Ib Study." Clinical Pharmacokinetics 56, no. 1 (2017). https://doi.org/10.1007/s40262-016-0417-0.
MLA (9th ed.) CitationGlund, Stephan, and Jörg Kreuzer. "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-blind, Crossover Phase Ib Study." Clinical Pharmacokinetics, vol. 56, no. 1, 2017, https://doi.org/10.1007/s40262-016-0417-0.